Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHE/300142 stock hub

SHE/300142 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/300142is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

21.4B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/300142

In the news

Latest news · SHE/300142

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E71.2

P25 17.1P50 24.2P75 37.8

Trailing P/E75.2

P25 23.5P50 41.3P75 83.2

ROE2.7

P25 -0.9P50 4.1P75 8.8

ROIC2.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/300142 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

CNY

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,981
Employees Change	-407%
Employees Change Percent	-17.04
Enterprise value	CNY 22.1B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100000WN2
Last refreshed	2026-05-10
Market cap	CNY 21.4B
Price	CNY 13.35
Price currency	CNY
Rev Per Employee	1,211,421.3x
Sector	Healthcare
Sic	2836
Symbol	she/300142
Website	https://www.walvax.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.34%
EV Earnings	77.51x
EV/EBIT	92.23x
EV/EBITDA	34.79x
EV/FCF	225.15x
EV/Sales	9.23x
FCF yield	0.46%
Forward P/E	71.2x
P/B ratio	2.73x
P/E ratio	75.24x
P/S ratio	8.9x
PE Ratio10 Y	186.51x
PE Ratio3 Y	218.8x
PE Ratio5 Y	180.98x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	10.01%
EBITDA Margin	26.08%
FCF margin	4.1%
Gross margin	73.33%
Gross Profit	CNY 1.8B
Gross Profit Growth	-8.5%
Gross Profit Growth Q	-8.04%
Gross Profit Growth3 Y	-27.1%
Gross Profit Growth5 Y	-9.13%
Net Income	CNY 285.8M
Net Income Growth	118.68%
Net Income Growth Q	4,082.41%
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Net Income Growth3 Y	-30.79%
Net Income Growth5 Y	-22.97%
Pretax Margin	12.91%
Profit Margin	11.91%
Profit Per Employee	CNY 144,257
Profitable Years	8
ROA	1.18
Roa5y	2.65
ROCE	2.63
ROE	2.69
Roe5y	4.59
ROIC	2.44
Roic5y	7.04

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.88%
Cagr15y	4.7%
Cagr1y	30.99%
Cagr3y	-23.93%
Cagr5y	-24.77%
Div CAGR10	2.92%
Div CAGR3	58.74%
Div CAGR5	-10.59%
EPS Growth	115.5
EPS Growth Q	3,970.6
EPS Growth Quarters	3
EPS Growth Years	1
EPS Growth3 Y	-30.89
EPS Growth5 Y	-23.4
FCF Growth	-79.66%
FCF Growth3 Y	-23.25%
OCF Growth	-33.47%
OCF Growth3 Y	-23.18%
OCF Growth5 Y	88.62%
Revenue Growth	-10.59x
Revenue Growth Q	-3.98x
Revenue Growth Years	0x
Revenue Growth3 Y	-23.04x
Revenue Growth5 Y	-5.95x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.19
Assets	CNY 11.1B
Cash	CNY 970.1M
Current Assets	CNY 4.3B
Current Liabilities	CNY 2B
Debt	CNY 1.4B
Debt EBITDA	CNY 2.14
Debt Equity	CNY 0.17
Debt FCF	CNY 13.85
Equity	CNY 7.8B
Interest Coverage	31.76
Liabilities	CNY 3.3B
Long Term Assets	CNY 6.8B
Long Term Liabilities	CNY 1.3B
Net Cash	CNY -392.9M
Net Cash By Market Cap	CNY -1.84
Net Debt EBITDA	CNY 0.63
Net Debt Equity	CNY 0.05
Net Debt FCF	CNY 3.99
Tangible Book Value	CNY 6.6B
Tangible Book Value Per Share	CNY 4.1
WACC	6.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.16
Inventory Turnover	1.01
Net Working Capital	CNY 1.8B
Quick ratio	1.67
Working Capital	CNY 2.3B
Working Capital Turnover	CNY 0.68

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.49%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.16
Dividend Years	8
Dividend Yield	1.16%
Ex Div Date	2026-01-09
Last Dividend	CNY 0.03
Payout Frequency	Annual
Payout Ratio	293.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	20.52%
1Y total return	30.97%
200-day SMA	12.17
3Y total return	-55.99%
50-day SMA	12.3
50-day SMA vs 200-day SMA	50over200
5Y total return	-75.89%
All Time High	96.73
All Time High Change	-86.2%
All Time High Date	2021-08-05
All Time Low	3.8
All Time Low Change	251.5%
All Time Low Date	2012-01-18
ATR	0.42
Beta	0.42
Beta1y	0.27
Beta2y	0.54
Ch YTD	22.37
High	13.59
High52	14.65
High52 Date	2026-01-26
High52ch	-8.87%
Low	13.19
Low52	10.01
Low52 Date	2025-05-29
Low52ch	33.37%
Ma50ch	8.58%
Price vs 200-day SMA	9.72%
RSI	63.78
RSI Monthly	44.23
RSI Weekly	59.77
Sharpe ratio	0.77x
Sortino ratio	1.56
Total Return	-0.33%
Tr YTD	22.69
Tr15y	99.25%
Tr1m	5.53%
Tr1w	0.91%
Tr3m	7.75%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 240.3M
Operating Income Growth Q	994.4
Operating Income Growth3 Y	-41.82
Operating Income Growth5 Y	-27.12
Operating margin	10.01

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,450,463,098%
Net Borrowing	867,849,181
Shares Insiders	6.33%
Shares Institutions	14.15%
Shares Out	1,599,348,541
Shares Qo Q	-0.14%
Shares Yo Y	1.49%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 98.4M
Average Volume	51,873,358.65x
Bv Per Share	4.63
CAPEX	CNY -534M
Ch10y	19.62
Ch15y	93.73
Ch1m	5.53
Ch1w	0.91
Ch1y	30.5
Ch3m	7.75
Ch3y	-56.2
Ch5y	-76.04
Ch6m	8.71
Change	1.52%
Change From Open	1.06
Close	13.15
Days Gap	0.46
Depreciation Amortization	385,696,197
Dollar Volume	1,050,114,150.6
Earnings Date	2026-04-28
EBIT	CNY 240.3M
EBITDA	CNY 626M
EPS	CNY 0.18
F Score	6
FCF	CNY 98.4M
FCF EV Yield	0.44x
FCF Per Share	CNY 0.06
Financing CF	-2,779,837,025
Fiscal Year End	December
Founded	2,001
Goodwill	33,657,636
Graham Number	4.30041
Graham Upside	-67.79
Income Tax	CNY 50.6M
Investing CF	-385,259,203
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2015-10-14
Last Split Type	Forward
Lynch Fair Value	CNY 0.89
Lynch Upside	-93.35
Ma150	12.07
Ma150ch	10.63%
Ma20	12.61
Ma20ch	5.85%
Net CF	-2,534,852,977
Next Earnings Date	2026-08-24
Open	13.21
P FCF Ratio	217
P OCF Ratio	33.76
Payment Date	2026-01-09
Position In Range	40
Ppne	4,015,017,387
Price Date	2026-05-08
Price EBITDA	CNY 34.11
Ptbv Ratio	3.26
Relative Volume	1.55x
Revenue	2,399,825,592x
Tax By Revenue	2.11x
Tax Rate	16.32%
Tr6m	9%
Volume	78,660,236
Z Score	4.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/300142 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.2%

$0.15 annual per share

Payout ratio

+294.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-10.6%

0 consecutive years of growth

Total shareholder yield

-0.3%

Next ex-dividend date: 2026-01-09

Performance

SHE/300142 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/300142?

Insider, institutional, and short-interest positioning.

Institutional ownership

+14.2%

Share of float held by funds and institutions

Insider ownership

+6.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.5%

Negative means the company is buying back shares.

Technical

SHE/300142 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

63.8

Neutral momentum band

Price vs 200-day MA

+9.7%

50/200-day relationship not available

Beta (5Y)

0.42

Less volatile than the market

Sharpe ratio

0.77

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/300142

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/300142 stock rating?

she/300142 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/300142 analysis?

The full report lives at /stocks/she/300142/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/300142?

The latest report frames she/300142 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/300142 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.